<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>21877405</identifier>
<setSpec>0034-0634</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Guillén García, Pedro</dc:author>
<dc:description xml:lang="en">In the last years a number of different tools which will be commonly used in the future have merged. Among them, the use of therapeutical cells (Cell Therapy) or the use of bio-active molecules after the identification of the molecular basis of a given pathology (Molecular Medicine), are two approaches. Currently, the autologous chondrocyte implantation to treat the articular cartilage lesions is considered as a consolidated therapy.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2010 </dc:date>
<dc:title xml:lang="es">Medicina celular y molecular en las lesiones del sistema músculo esquelético (deporte). (Células para curar).</dc:title>
<dc:title xml:lang="en">[Cell and molecular medicine in musculoskeletal system lession (sports) (healing cells)].</dc:title>
<dc:publisher>Anales de la Real Academia Nacional de Medicina</dc:publisher>
</metadata>
</record>
</pubmed-document>
